Back to How We Help Clients


As competition intensifies and payors restrict reimbursement, more pharmaceutical, biotech, and medical product companies are trying to maximize profits through operational improvement. But their efforts are often complicated by the increasing complexity of the healthcare landscape, such the shift of manufacturing to low-cost countries and the need for more intricate supply chains to meet growing demand in emerging markets.

McKinsey has decades of experience in all aspects of pharmaceutical operations, allowing us to help clients identify opportunities for revenue enhancement, efficiency improvement, and cost reduction throughout the entire production cycle. Over the past five years, we have served pharmaceutical, biotech, and medical product clients in more than 850 operations engagements, giving us a detailed understanding of all industry trends and challenges. We take a hands-on approach to working with clients, creating practical strategies that generate bottom-line impact. To sustain long-term improvement, we emphasize helping clients build their internal capabilities, providing tailored training programs for all organizational levels. We also have developed a set of tools and databases specifically for pharmaceutical operations, focusing on benchmarks in manufacturing cost, productivity, supply chain, purchasing, procurement and quality performance.

For more details about our expertise, please visit the Operations Practice page.

Our work covers six main areas below. 

Featured experts

Parag Patel

Partner, Chicago

Thibaut Dedeurwaerder

Partner, Brussels

Katy George

Senior Partner, New Jersey

Featured Capabilities

Supply chain management

We take the customer's perspective to develop an end-to-end view of the supply chain, working with companies to define strategy, redesign distribution networks, benchmark performance, identify problems, improve service levels, manage risk, reduce backorders, and lower inventory.

Network strategy

We help clients determine if their networks are aligned with their overall company strategy and goals. We also help clients capture value by optimizing global plant configurations, identifying opportunities to shift production to low-cost countries, assisting with plant closures or transfer of operations, ramping up production at new sites, and selecting locations for greenfield projects.


Improve performance across key production parameters—including cost, delivery, service, and quality—by developing the capabilities of the workforce at scale.

Quality, compliance, and remediation

Life sciences companies that proactively manage their quality functions can generate value far beyond improved regulatory compliance. Smart quality builds on the existing objectives of unconditionally delivering on patient safety and regulatory requirements in a cost-efficient way. Quality becomes a value-added partner and coach that helps integrate compliance into regular operations while enabling speed and effectiveness. Our extensive expertise includes digitization and automation of quality processes, risk-based process redesign that deploys newest design-thinking methodology, benchmarking of quality cost and performance, optimization of quality management systems, compliance and remediation services, and fostering a quality culture.

External supply

We have a thorough understanding of external suppliers and contract management organizations (CMOs), including their capabilities and typical costs. Through our market knowledge and experience, we have helped clients capture both immediate and sustainable value in multiple projects. Our approach entails working with clients to create a comprehensive external supply strategy, segment suppliers, develop metrics for vendor performance, and establish clear management guidelines to optimize value from third-party suppliers.

Product development and lifecycle strategy

We support clients throughout the end-to-end product lifecycle. Our areas of expertise include enhancing operations during the development of new product and platform strategies, conducting diagnostics to determine readiness for launch and acceleration, developing strategies for mature products, and optimizing costs. For medical product companies, we also offer tools that enhance quality, improve manufacturing processes, and increase their products' appeal to customers.


POBOS provides information on cost, productivity and quality, supply chain performance, and quality performance across more than 35 pharmaceutical and biotech companies. Companies can use the information to understand productivity drivers and their impact and quickly focus efforts on the highest value areas. Visit the POBOS site.

Related insights

Winter is coming: What’s next in COVID-19 testing

– The upcoming flu season in the Northern Hemisphere is expected to increase demand for COVID-19 testing. Decision makers may ask: Will there be enough flexible testing capacity to respond to global demand and avoid second lockdowns?

Reimagining supply chain resilience

– Company executives are looking to more deeply understand their supply chains, shift from “just-in-time” to a more robust inventory management approach, and increase their supply chain transparency and resilience, writes Kweilin Ellingrud in Forbes.

Automation and the future of work in the US biopharma industry

– The US biopharma industry has been slower than some others to embrace enterprise-wide automation. As it accelerates adoption, it will radically alter the future of work for its employees.

Pharma operations: The path to recovery and the next normal

– Pharma operations leaders have increased their focus on network risk management, agile and transparent operations, and shaping the workforce of the future in the post-COVID-19 path to recovery.

Pharma operations: Creating the workforce of the future

– Reskilling employees to address talent gaps can help a company retain the bulk of its operations workers and empower them to take advantage of a new world.

Rethinking manufacturing and distribution networks in medtech

– Changes in the medtech market have left many companies struggling with their operational footprints. A network redesign can help them save costs, increase flexibility, and create a competitive edge.

Digitization, automation, and online testing: The future of pharma quality control

– Emerging technologies can make quality control (QC) faster and more efficient. What do pharma companies need to do to become QC leaders?

How data is changing the pharma operations world

– Pharma companies have a great opportunity to turn a buzzword into exponential impact.